Tripos Inc. said Monday it will collaborate with Abbott Laboratories to design, synthesize and purify high-quality, drug-like compounds to expand Abbott’s compound file collection.
Tripos Inc. said Monday it will collaborate with Abbott Laboratories to design, synthesize and purify high-quality, drug-like compounds to expand Abbott’s compound file collection.
